Key Takeaways From The White House Clinical Trials Forum
The White House Clinical Trials Forum brought together key leaders in science, healthcare, and patient advocacy to address the...
Adaptive Clinical Trial Design Adaptive Trial Design AI in Clinical Trials alcohol use disorder Alzheimer's Disease Article Artificial Intelligence in Clinical Trials Clinical Operations Clinical Research Clinical Trial Design Clinical Trial Innovation Clinical Trial Operations Clinical Trial Ops Brief Clinical Trials CLINOPS WATCHDOG CNS Trials Conference Coverage Decentralized Clinical Trials Digital Health Technologies DOGE FDA Budget Cuts eClinical Tech News eClinical Technology EMA Executive Interviews FDA Enforcement FDA Guidance FDA Real-World Evidence FDA Regulation FDA Regulatory Strategy GCP Compliance GLP-1 Receptor Agonists Ketamine Therapy Oncology Trials Opinion Parkinson's Disease Platform Trials protocol amendments Psilocybin MDMA Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site activation Site Operations study startup Treatment-Resistant Depression
The White House Clinical Trials Forum brought together key leaders in science, healthcare, and patient advocacy to address the...
QPS, a prominent global contract research organization, has introduced enhanced laboratory services at its Springfield, Missouri unit. This expansion...
The U.S. Food and Drug Administration (FDA) has approved an Investigational New Drug (IND) application and granted Fast Track...
DiaMedica Therapeutics, a biotechnology company, is expanding its clinical development program for DM199 into preeclampsia. Preeclampsia is a severe...
Cybin Inc., a biopharmaceutical company focused on developing treatments for mental health disorders, has achieved significant milestones in its...
Importance of Critical Thinking Skills in Clinical Trial Management The 3rd Clinical Quality Oversight Conference, run by Momentum Events...
In recent years, clinical trial respiratory technology advancements have revolutionized how to monitor and assess treatment efficacy for respiratory...
The 3rd Clinical Quality Oversight Conference, run by Momentum Events in May of 2024, opened with a critical presentation...
Leslie Sam, President, Leslie Sam and Associates, LLC and Lisa Collins, Co-Founder, Head of Clinical Research at Innomas Clinical...
Merck KGaA, a renowned science and technology company, has discontinued its Phase III clinical trials for xevinapant in treating...